These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 121849)

  • 1. [In vitro immunologic changes in 4 patients with lepromatous leprosy treated for 1 year with rifampicin and sulfones and left untreated the following year].
    Saint-André P
    Acta Leprol; 1979; (76-77):301-2. PubMed ID: 121849
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polychemotherapy of leprosy in a rural area].
    Languillon J
    Acta Leprol; 1988; 6(5):67-71. PubMed ID: 3271378
    [No Abstract]   [Full Text] [Related]  

  • 3. A century of progress in the therapy of leprosy.
    Karat AB; Ramanujam K
    Int J Lepr Other Mycobact Dis; 1973; 41(3):382-91. PubMed ID: 4130572
    [No Abstract]   [Full Text] [Related]  

  • 4. Introductory rifampicin therapy in lepromatous leprosy: a six month follow-up study.
    Girdhar BK; Ramu G; Sreevatsa ; Desikan KV
    Lepr India; 1978 Jul; 50(3):363-70. PubMed ID: 359925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of single dose (1500 mg) rifampicin on infectivity of patients with lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jul; 52(3):359-65. PubMed ID: 7206633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of L-tetramisol associated with rifampicin in patients with lepromatous leprosy. L-tetramisol in patients with lepromatous leprosy].
    Galmarini M; Riera CM; Ripoll J; Orozco MA; Katz J
    Med Cutan Ibero Lat Am; 1978; 6(3-4):179-83. PubMed ID: 398916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quadriplegia, in lepromatous leprosy previously cleared-up, diffuse polyneuritis which appeared in spite of 6 years of follow-up consolidating treatment with Sultirene alone].
    Merklen FP; Cottenot F; Pennec J; Vernant JC; Buzacoux J
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):461-2. PubMed ID: 5150887
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of three-year multidrug therapy in multibacillary leprosy patients.
    Li W; Ye G; Yang Z; Tao M; Luo J; Wang C; Ji F
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(1):37-40. PubMed ID: 2371263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Initial otorhinolaryngologic lesions of lepromatous leprosy].
    Vallés H; Blanc J; Fumanal L; Abenia J; de Francisco J; Cervera C
    An Otorrinolaringol Ibero Am; 1992; 19(1):77-86. PubMed ID: 1554091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary clinical trial of rifampicin in leprosy.
    Bhide MB; Desai AC; Ganapati R
    Lepr India; 1976 Oct; 48(4 Suppl):781-3. PubMed ID: 1026816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial with rifampicin in the treatment of leprosy.
    Ghosh S; Hazra SK; Kundu S; Choudhury S
    Lepr India; 1976 Oct; 48(4 Suppl):775-80. PubMed ID: 800236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cell-mediated immunity in patients with leprosy treated with rifampicin].
    Valdés-Portela A; de la Cruz F
    Rev Cubana Med Trop; 1987; 39(3):23-32. PubMed ID: 3327106
    [No Abstract]   [Full Text] [Related]  

  • 16. Intermittent rifampicin therapy in lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jan; 52(1):89-96. PubMed ID: 6991816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of leprosy endemicity and bacterial positivity of lepromatous patients under treatment with sulfones.
    Bechelli LM; Dominguez VM
    Int J Lepr Other Mycobact Dis; 1971; 39(2):461. PubMed ID: 5169809
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifampicin (RFP) trial in lepromatous leprosy.
    Koticha KK; Pade SS; Chulawala RG; Juwatkar PS
    Lepr India; 1982 Jul; 54(3):441-7. PubMed ID: 6757577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.